Setmelanotide is under consideration for other rare genetic disorders associated with obesity including Bardet–Biedl syndrome, Alstrom syndrome, POMC, and other MC4R pathway heterozygous deficiency obesities. The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.